![](/img/cover-not-exists.png)
P-195 Bexarotene improves 1-year survival in untreated, advanced NSCLC, when given in combination with carboplatin/paclitaxel
Bordoni, R., Khanwani, S., Saleh, M., Auerbach, M., Steinbaum, F., Page, T.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80689-0
Date:
July, 2005
File:
PDF, 144 KB
english, 2005